Case 2-2012: a 57-year-old woman with post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for primary myelofibrosis

Abstrakt

Allogeneic haematopoietic stem cell transpantation (HSCT) has become a major life sustaining treatment for haematopoietic disorders, and it is the preffered treatment option for selected patients with idiopatic myelofibrosis. Still, it may be accompanied by various complications.

Here, we present a case of Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), i.e. an infection-induced malignant proliferation following HSCT.

Klíčová slova

• Allogeneic haematopoietic stem cell transpantation (HSCT)
• post-transplant lymphoproliferative disorder (PTLD)
• Epstein-Barr virus (EBV)
• haematopoietic disorders
• infection-induced